Menu
GeneBe

X-48802743-G-C

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 1P and 8B. PP2BP4_StrongBS2

The NM_006044.4(HDAC6):c.51G>C(p.Arg17Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000389 in 1,207,114 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 16 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00022 ( 0 hom., 6 hem., cov: 23)
Exomes 𝑓: 0.000020 ( 0 hom. 10 hem. )

Consequence

HDAC6
NM_006044.4 missense

Scores

1
2
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.0550
Variant links:
Genes affected
HDAC6 (HGNC:14064): (histone deacetylase 6) Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene belongs to class II of the histone deacetylase/acuc/apha family. It contains an internal duplication of two catalytic domains which appear to function independently of each other. This protein possesses histone deacetylase activity and represses transcription. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

PP2
Missense variant where missense usually causes diseases, HDAC6
BP4
Computational evidence support a benign effect (MetaRNN=0.02738434).
BS2
High Hemizygotes in GnomAd at 6 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
HDAC6NM_006044.4 linkuse as main transcriptc.51G>C p.Arg17Ser missense_variant 2/29 ENST00000334136.11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
HDAC6ENST00000334136.11 linkuse as main transcriptc.51G>C p.Arg17Ser missense_variant 2/291 NM_006044.4 P2Q9UBN7-1

Frequencies

GnomAD3 genomes
AF:
0.000225
AC:
25
AN:
111132
Hom.:
0
Cov.:
23
AF XY:
0.000180
AC XY:
6
AN XY:
33320
show subpopulations
Gnomad AFR
AF:
0.000818
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000568
AC:
10
AN:
176195
Hom.:
0
AF XY:
0.0000325
AC XY:
2
AN XY:
61507
show subpopulations
Gnomad AFR exome
AF:
0.000716
Gnomad AMR exome
AF:
0.0000371
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000201
AC:
22
AN:
1095930
Hom.:
0
Cov.:
31
AF XY:
0.0000277
AC XY:
10
AN XY:
361488
show subpopulations
Gnomad4 AFR exome
AF:
0.000797
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000217
GnomAD4 genome
AF:
0.000225
AC:
25
AN:
111184
Hom.:
0
Cov.:
23
AF XY:
0.000180
AC XY:
6
AN XY:
33382
show subpopulations
Gnomad4 AFR
AF:
0.000817
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.000268
ESP6500AA
AF:
0.000261
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000107
AC:
13

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 13, 2021The c.51G>C (p.R17S) alteration is located in exon 2 (coding exon 1) of the HDAC6 gene. This alteration results from a G to C substitution at nucleotide position 51, causing the arginine (R) at amino acid position 17 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.48
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.42
Cadd
Benign
15
Dann
Benign
0.95
FATHMM_MKL
Benign
0.25
N
LIST_S2
Benign
0.85
D;T;.;T;.;.;.;.;.;D;.;D;D;T;D
M_CAP
Benign
0.033
D
MetaRNN
Benign
0.027
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.98
T
MutationTaster
Benign
1.0
N;N;N;N
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-1.1
N;D;N;N;N;.;N;N;.;.;.;.;N;N;N
REVEL
Benign
0.081
Sift
Uncertain
0.015
D;D;D;D;D;.;D;D;.;.;.;.;D;D;D
Sift4G
Pathogenic
0.0
D;D;D;D;T;.;T;T;.;.;.;.;D;D;D
Polyphen
0.42, 0.94
.;.;.;.;B;P;B;B;P;.;B;B;P;.;.
Vest4
0.35, 0.29
MutPred
0.21
Gain of phosphorylation at R17 (P = 6e-04);Gain of phosphorylation at R17 (P = 6e-04);Gain of phosphorylation at R17 (P = 6e-04);Gain of phosphorylation at R17 (P = 6e-04);Gain of phosphorylation at R17 (P = 6e-04);Gain of phosphorylation at R17 (P = 6e-04);Gain of phosphorylation at R17 (P = 6e-04);Gain of phosphorylation at R17 (P = 6e-04);Gain of phosphorylation at R17 (P = 6e-04);Gain of phosphorylation at R17 (P = 6e-04);Gain of phosphorylation at R17 (P = 6e-04);Gain of phosphorylation at R17 (P = 6e-04);Gain of phosphorylation at R17 (P = 6e-04);Gain of phosphorylation at R17 (P = 6e-04);Gain of phosphorylation at R17 (P = 6e-04);
MVP
0.62
MPC
1.0
ClinPred
0.022
T
GERP RS
-0.23
Varity_R
0.25
gMVP
0.42

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs375722411; hg19: chrX-48661150; API